BSPM Stock Overview
Biostar Pharmaceuticals, Inc. desarrolla, fabrica y comercializa productos farmacéuticos de venta libre y con receta para diversas enfermedades y afecciones en la República Popular China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Biostar Pharmaceuticals, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0095 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -98.95% |
| 1 Year Change | n/a |
| 3 Year Change | -99.94% |
| 5 Year Change | -99.93% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| BSPM | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | -0.2% |
| 1Y | n/a | 20.4% | 25.7% |
Rentabilidad frente al sector: Datos insuficientes para determinar los resultados de BSPM en comparación con el sector US Pharmaceuticals .
Rentabilidad vs. Mercado: Datos insuficientes para determinar el rendimiento de BSPM frente al mercado US.
Price Volatility
| BSPM volatility | |
|---|---|
| BSPM Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: BSPMha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de BSPM en el último año.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Ronghua Wang | https://biostarpharmaceuticals.com |
Biostar Pharmaceuticals, Inc. desarrolla, fabrica y comercializa productos farmacéuticos de venta libre y con receta para diversas enfermedades y afecciones en la República Popular China. La empresa ofrece principalmente la cápsula de ácido oleanólico Xin Ao Xing, un medicamento OTC para la hepatitis B crónica. También ofrece otros 12 productos OTC y 17 productos farmacéuticos de prescripción.
Biostar Pharmaceuticals, Inc. Fundamentals Summary
| BSPM fundamental statistics | |
|---|---|
| Market cap | US$263.00 |
| Earnings (TTM) | US$934.35k |
| Revenue (TTM) | US$317.79k |
0.0x
P/E Ratio0.0x
P/S RatioIs BSPM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BSPM income statement (TTM) | |
|---|---|
| Revenue | US$317.79k |
| Cost of Revenue | US$354.54k |
| Gross Profit | -US$36.75k |
| Other Expenses | -US$971.10k |
| Earnings | US$934.35k |
Last Reported Earnings
Sep 30, 2017
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BSPM perform over the long term?
See historical performance and comparison